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Objective: To investigate whether Fourier transform infrared imaging spectroscopy (FT-IRIS), a modality
based on molecular vibrations, is a viable alternative to histology and immunohistochemistry (IHC) for
assessment of tissue quality and patient clinical outcome.
Methods: Osteochondral biopsies were obtained from patients (9e65 months post-surgery) who
underwent an autologous chondrocyte implantation (ACI) procedure to repair a cartilage defect (N ¼ 14).
The repair tissue was evaluated histologically by OsScore grading, for the presence of types I and II
collagen by IHC, and for proteoglycan (PG) distribution and collagen quality parameters by FT-IRIS.
Patient clinical outcome was assessed by the Lysholm score.
Results: Improvement in Lysholm score occurred in 79% of patients. IHC staining showed the presence of
types I and II collagen in all samples, with a greater amount of collagen type II in the deep zone. The
amount and location of immunostaining for type II collagen correlated to the FT-IRIS-derived parameters
of relative PG content and collagen helical integrity. In addition, the improvement in Lysholm score post-
ACI correlated positively with the OsScore, type II collagen (IHC score) and FT-IRIS-determined param-
eters. Regression models for the relation between improvement in Lysholm score and either OsScore, IHC
area score or the FT-IRIS parameters all reached signiﬁcance (p < 0.01). However, the FT-IRIS model was
not signiﬁcantly improved with inclusion of the OsScore and IHC score parameters.
Conclusion: Demonstration of the correlation between FT-IRIS-derived molecular parameters of cartilage
repair tissue and patient clinical outcome lays the groundwork for translation of this methodology to the
clinical environment to aid in the management of cartilage disorders and their treatment.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Damage or degeneration of cartilage is frequently associated
with joint pain and with changes in the macromolecular structure
and content of the primary cartilage components1e5. It is widely
accepted that cartilage injuries do not heal spontaneously1, which
is related in part to the avascular nature of the tissue and low
mitotic activity of chondrocytes6. A variety of approaches have been
investigated to improve cartilage healing including microfracture7,
subchondral drilling7, osteochondral grafting8, bone-marrow
stimulation and a one-step technique based on bone marrow-
derived cell transplantation9. These techniques rely on theto: N. Pleshko, College of
2, USA. Tel: 1-215-204-4280.
).
s Research Society International. Ppotential of non-differentiated cells located in the subchondral area
to migrate into the defect region and to differentiate into active
chondrocytes10,11. More cell based methods for the repair of artic-
ular cartilage have also been developed on the basis of autologous
cartilageebone transplants or transplantation of cultured autolo-
gous chondrocytes8,12. Autologous chondrocyte implantation (ACI)
is being used increasingly to treat cartilage defects13. This proce-
dure aims to stimulate autologous cells to synthesize the extra-
cellular matrix components of articular cartilage and to generate
a zonal structure similar to normal articular cartilage14. Brittberg
et al.12 applied the ACI technique clinically for the ﬁrst time with
good to excellent results for healing. A number of studies followed
with similar results, suggesting that ACI is an effective procedure
for healing cartilage defects of the knee1,15e17.
Evaluation of the success of cartilage repair procedures can
include assessment of tissue harvested from the repair site, and
several scoring systems are in use for semi-quantitative histological
tissue evaluations18, including the ICRS II score19, O’Driscoll score20ublished by Elsevier Ltd. All rights reserved.
Table I
Parameters evaluated in the Lysholm score (total 100
points)40
Parameter Points
Limp Five points
Support Five points
Stair climbing 10 points
Squatting Five points
Instability 25 points
Pain 25 points
Swelling 10 points
Locking 15 points
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integrity, proteoglycan (PG) staining, chondrocyte clustering,
presence of hyaline cartilage, and integration of repair with
surrounding tissue. In addition, the presence of type II collagen in
repair tissue is an important indicator of successful articular
cartilage repair22,23, as mechanically inferior ﬁbrocartilaginous
tissue that contains type I collagen is often produced24. Therefore,
immunohistochemical assessment of types I and II collagen is often
performed as well14,25. The major drawback for both histological
and immunohistochemical assessment is the requirement to
harvest tissues for analysis, which limits these evaluations in
a clinical scenario.
Fourier transform infrared imaging spectroscopy (FT-IRIS) has
been used to characterize the structure, distribution and orienta-
tion of extracellular matrix molecules, including types I and II
collagen and PG, in histological sections of connective tissues26, and
in particular, in diseased and regenerative or engineered
cartilage4,27e34. Further, the use of infrared spectroscopic tech-
niques via ﬁber optic enables assessment of tissues in situ, without
biopsy35,36. Thus, the possibility of utilizing these methods to
monitor cartilage repair tissue quality, and thereby assist in disease
management, is attractive. In particular, if parameters derived from
infrared spectral characterization of repair tissue correlate with
traditional histology-derived scores or with patient clinical
outcome, FT-IRIS would provide a means to non-destructively
assess the tissue status and could perhaps predict success of the
repair procedure.
To date, there has been limited success in correlating the clinical
outcome of patients who have undergone cartilage repair proce-
dures with the quality of the repair tissue formed21,23. The aims of
the current study were, therefore three-fold, namely (1) to inves-
tigate the molecular properties of cartilage repair tissue post-ACI
procedure using FT-IRIS, (2) to assess correlations between FT-
IRIS-derived properties and the gold-standard techniques of
histological grading and type II collagen IHC and (3) to investigate if
FT-IRIS is a viable alternative to histological or immunochemical
assessment by exploring the relationship between histological,
immunohistochemical, or FT-IRIS assessment of tissue quality and
clinical outcome.
Materials and methods
Tissue
Patients, aged 28e53 years (N ¼ 14), with chondral or osteo-
chondral defects on the femoral condyles or trochlea, were treated
with ACI according to the technique of Brittberg et al.12. Full-depth
core biopsy samples (1.8 mm in diameter) were obtained from
patients who had undergone ACI 9e65 months previously. In
addition, tissue from a healthy cadaveric knee (40-year-old) with
macroscopically normal cartilagewas obtainedwithin 24 h of death
from the UK Human Tissue Bank. A biopsy was obtained from the
medial femoral condyle, similar to the region most commonly
treated with ACI. All tissues obtained were under approval of the
local Research Ethical Committee. The tissues were immediately
snap frozen and stored in liquid nitrogen until processed.
Clinical outcome (Lysholm score)
Patient clinical outcome was evaluated based on the Lysholm
score37,38. The Lysholm scale is a well-validated functional and pain
score designed for knee injuries that has been utilized to assess the
clinical outcome of ACI procedures37,39 and ranges from 0 (poor
outcome) to 100 (best). The parameters that comprise the Lysholm
score are summarized in Table I40. For each patient, the Lysholmscore was assessed at the time of surgery (pre-operatively) and at
the time of biopsy; the difference between these two values was
reported as the actual improvement in Lysholm score, or percent
Lysholm improvement.
Histology and IHC analysis
Seven-micron thick cryosections of the harvested biopsies were
stainedwith hematoxylin and eosin (H&E) for histologic evaluation.
The semi-quantitative OsScorewas utilized for assessment of tissue
quality21, and ranges from 0 (worst) to 10 (best), based on the
following features of the repair tissue: cartilage type present
(hyaline cartilage, ﬁbrocartilage or ﬁbrous tissue), integrity of the
tissue surface, degree of metachromasia (toluidine blue or safranin
O staining), formation of chondrocyte clusters, presence of blood
vessels or mineralization, and integration with the calciﬁed carti-
lage and underlying bone.
Immunohistochemical staining was performed on cryosections
using antibodies speciﬁc to types I or II collagen. Separate tissue
sections were incubated for 1 h at room temperature with primary
antibodies against type I collagen (monoclonal antihuman, clone no
1-8H5; ICN) and against type II collagen (CIICI; Developmental
Studies Hybridoma Bank, Iowa, USA). The type II collagen stained
IHC images were scored in two ways. A semi-quantitative assess-
ment of the percentage of area of the section of cartilage tissue
which was immunostained for type II collagen, termed ‘IHC Area
score’, was obtained using image analysis software (NIS-Elements
Basic Research, Nikon, Japan)14. A secondmore detailed assessment
of the staining intensity in deﬁned regions was also undertaken on
a number of samples and used to determine the relationship of the
IHC intensity (termed as ‘IHC Intensity score’) with FT-IRIS-derived
parameters. For this, each tissue section was divided into nine
regions and each region graded from 0 to 3 based on staining
intensity, where grade 0 represents the minimum amount of type II
collagen staining (white) and grade 3 represents the maximum
amount of type II collagen immunostaining (dark brown).
FT-IRIS data acquisition
FT-IRIS data were acquired in the mid-infrared region,
4000e800 cm1, at 8 cm1 spectral resolution and 25 mm spatial
resolution, with two co-added scans per pixel, using a Spectrum
Spotlight 400 FT-IR imaging spectrometer (Perkin Elmer, CT, USA).
Polarized FT-IRIS data were collected with an infrared polarizer
inserted in the beam path. Data collection time was approximately
30 min/sample.
FT-IRIS data processing
FT-IRIS images were created based on vibrational absorbances
for the speciﬁc molecular components of interest in cartilage using
ISys software v5.0 (Malvern Instrument, Columbia, MD, USA)28.
Fig. 1. Percentage LSI 9e65 months post-ACI treatment (A) for each individual patient,
(B) vs patient age, and (C) vs time of biopsy.
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composition of cartilage, based on absorbances from different
components. An earlier study from our lab where spectroscopic
evaluation of mixtures of pure collagen and aggrecan (the major PG
in cartilage) was performed demonstrated that the integrated area
under the protein amide I band (1594e1718 cm1) correlates with
collagen content26. In the same study, it was shown that the inte-
grated area of the infrared vibration from the sugar ring absorbance
of PGs in the range of 985e1140 cm1 correlates with PG content.
Although more recent studies have shown some improvement in
speciﬁcity of PG assessment using multivariate methodology41, the
PG parameters used in the current study have been validated by
correlation to both biochemical and histology data34,42. The ratio of
the integrated area of the PG absorbance to the amide I collagen
absorbance (PG/Am I) was evaluated to obtain the relative quantity
and distribution of the PG component with respect to collagen. The
area under the infrared absorbance centered at 1338 cm1
(1326e1356 cm1), a feature attributed to CH2 side-chain vibra-
tions in collagen, has previously been shown to decrease in inten-
sity as collagen denatures35,43, and thus is related to whether the
collagen triple helix is intact. This absorbance was ratioed to the
amide II band (1492e1594 cm1) to evaluate the helical integrity of
collagen, and deﬁned as “collagen integrity”43.
The area ratio of the amide I and amide II absorbances from
collagen was used to create the images from the polarized data. It
has previously been shown that this ratio can be used as an index of
collagen ﬁbril orientation44. The collagen ﬁbril orientation was
deﬁned as: (1) an amide I/II polarized ratio2.7 representing ﬁbrils
parallel to the articular surface, (2) an amide I/II ratio 1.7
reﬂecting ﬁbrils perpendicular to the articular surface, and (3)
amide I/II ratios between 2.7 and 1.7 indicative of random or mixed
ﬁbril orientation44.
Statistical analysis
A Pearson correlation analysis was used to assess the relation-
ship between the FT-IRIS data, Lysholm score improvement (LSI),
histology OsScore and IHC data. Mean values, p-value and 95%
conﬁdence intervals (95% CI) were calculated for descriptive
statistics. To assess whether FT-IRIS-derived data have the potential
to replace histological and immunohistochemical assessment,
a multiple linear regression analysis was used to investigate the
relationship between tissue quality as reﬂected in FT-IRIS-derived
properties, OsScore, or IHC data, or a combination of these data
and the clinical outcome (LSI). In this analysis, LSI was regarded as
the dependent variable and all other variables as independent. The
strength of the relationships was assessed based on R-squared (R2)
values and root mean square errors (RMSEs) of the models from the
regression analysis. An F-test was used to assess whether addition
of extra variables improved the models signiﬁcantly45. Signiﬁcance
was determined at p  0.05 for all analyses. All data were analyzed
in Unscrambler X software (Camo, Norway) and Microsoft Excel
2010.
Results
There was a wide range of change in Lysholm scores following
treatment with ACI, with an improvement in Lysholm score
occurring in 11 of the 14 patients [79%; Fig. 1(A)]. There was no
signiﬁcant correlation between the percentage improvement in
Lysholm score and the age of the patient [Fig. 1(B), R ¼ 0.1, 95%
CI0.43 to 0.58, p¼ 0.72], or time of biopsy [Fig. 1(C), R¼ 0.02, 95%
CI 0.49 to 0.52, p ¼ 0.94].
Immunohistochemical staining demonstrated the presence of
types I and II collagen in the tissue samples (Fig. 2). The type IIcollagen immunostaining typically occurred in the lower part of the
biopsy core, close to the underlying bone, covering an average of
60% area of the cartilaginous section, while staining for type I
collagen was present throughout the majority of the cores.
FT-IRIS analysis demonstrated that collagen [Fig. 3(A)] and PG
[Fig. 3(B, C)] were also distributed zonally in the repair tissue,
where more abundant collagen and PG were present in the middle
and deep zones of the cartilage, respectively. Both PG and collagen
content were higher in the normal cartilage sample compared to
repair cartilage biopsies. Collagen helical integrity was also greater
in the normal cartilage compared to repair tissue [Fig. 3(D)]. In
contrast to normal cartilage, where the collagen ﬁbrils were
oriented parallel to the articular surface at the superﬁcial zone,
random in the middle, and perpendicular to the surface in the deep
zone, there was no completely normal zonal distribution of
Fig. 2. IHC staining for types I and II collagen antibodies from of a subset of ACI-treated biopsy samples.
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Most repair biopsy samples showed the FT-IRIS parameter reﬂect-
ing collagen ﬁbers to be more randomly oriented through the full
depth of tissue than in normal cartilage.
FT-IRIS-derived PG/Am I integrated area ratio, indicative of the
relative PG/collagen content of the repair tissue, was highest in the
tissue adjacent to the bone for all samples [Fig. 4(A)]. Similarly,
there were higher values for the collagen helical integrity in the
areas near the bone than elsewhere in the repair tissue [Fig. 4(B)].
Qualitatively, the distribution of both these parameters was very
similar to the distribution of type II collagen [Fig. 4(C)].Fig. 3. FT-IRIS images from a subset of ACI-treated biopsy samples and from normal cartila
respectively, for (A) collagen, (B) PG, (C) relative PG, (D) collagen helical integrity, and (E) co
surface, between 1.7 and 2.7 indicate randomly aligned ﬁbers, and larger than 2.7 indicateHistology showed that generally, the surface zone was smooth
and there was good basal integration between the repair tissue and
the underlying bone [Fig. 4(D)]. OsScore values ranged from 2.5 to
9, with cartilage morphology being predominantly ﬁbrocartilage in
seven cores, hyaline cartilage in three cores, and a mixture of
hyaline and ﬁbrocartilage morphology in the remaining four cores.
The IHC intensity score was signiﬁcantly correlated with
PG/Am I [R ¼ 0.95, 95% CI 0.93e0.97, p < 0.0001, Fig. 5(A)], with
collagen helical integrity [R ¼ 0.97, 95% CI 0.96e0.98, p < 0.0001,
Fig. 5(B)] and with the OsScore [R ¼ 0.78, 95% CI 0.43e0.93,
p ¼ 0.001, Fig. 5(C)].ge. The red and dark blue in the color scales indicate the highest and lowest content,
llagen ﬁbril orientation, where values less than 1.7 indicate ﬁbers perpendicular to the
collagen ﬁbers with orientation parallel to the articular surface, respectively.
Fig. 4. FT-IRIS-derived parameters from a subset of ACI-treated biopsy samples. (A) PG/collagen content, and (B) collagen helical integrity. Corresponding IHC image of (C) collagen
type II staining, and (D) histology image of H&E staining.
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treatment (at the time of the biopsy) was signiﬁcantly correlated
with collagen helical integrity [R ¼ 0.78, 95% CI 0.43e0.93,
p¼ 0.001, Fig. 6(A)], PG/Am I [R¼ 0.69, 95% CI 0.25e0.89, p¼ 0.006,
Fig. 6(B)], the IHC area score [R ¼ 0.70, 95% CI 0.27e0.90, p ¼ 0.005,
Fig. 6(C)], and the OsScore [R ¼ 0.68, 95% CI 0.25e0.88, p ¼ 0.007,
Fig. 6(D)].
In line with the correlation analysis, regression models for the
relation between percentage LSI as dependent and either OsScore,
IHC area score or the FT-IRIS parameters as independent parame-
ters all reached signiﬁcance [Equations (1)e(3), Table II]. Once the
information from the FT-IRIS parameters was taken into account,
addition of the IHC area score, the OsScore or both, slightly
increased the coefﬁcient of determination (R2) of the relation
between the independent parameters and the LSI [Equations (4)
and (5), Table II]. However, this increase in R2 was not signiﬁcant
(p ¼ 0.07 or more; Table II).
LSI ¼ 9:22*OsScore 33:89 (1)
LSI ¼ 0:47*IHC area score 15:17 (2)
LSI ¼ 16:95þ 0:95*PG=Am I þ 1:56*collagen integrity (3)
LSI ¼ 12:72þ 0:51*IHC area scoreþ 0:325*PG=Am I
þ 1:57*collagen integrity (4)
LSI ¼ 3:41þ 2:57*OsScoreþ 0:4*IHC area score
þ 0:325*PG=Am Iþ 0:968*collagen integrity (5)Discussion
In the current study, we found that the ACI procedure improves
clinical outcome as measured using the Lysholm score in themajority of patients. The repair tissue was generally composed of
both types I and II collagen, with highest concentrations of type II
collagen in the cartilage deep zone near to the calciﬁed tissue. The
type II collagen distribution was similar to the relative PG/collagen
and helical integrity maps obtained from the FT-IRIS data. Param-
eters calculated from the FT-IRIS data correlated highly and
signiﬁcantly with the histological and immunohistochemical data
as characterized by OsScore and IHC area, respectively. All three
also correlated highly with the clinical outcome characterized by
increase in Lysholm score post-treatment. Multiple regression
analysis showed that once the information from the FT-IRIS
parameters was taken into account, information from neither the
OsScore nor the IHC score could signiﬁcantly improve the relation
between FT-IRIS and clinical outcome.
Repair procedures for articular cartilage are particularly useful
when the function of the joint can be signiﬁcantly recovered and
progression to joint degeneration can be inhibited or slowed7. It is
important to monitor clinical progress, as well as tissue changes,
post-treatment. In the current study, clinical improvement
occurred in 79% of patients, similar to previous studies that
reported a 65e90% success rate of ACI treatments1,15,17. However,
the range of values for magnitude of improvement is large,
underscoring both the subjective nature of assessment, and the
heterogeneity of the population and procedure. Increased under-
standing of the molecular basis that underlies the clinical
improvement could aid in the management of the repair process.
Immunostaining using antibodies that react with speciﬁc
collagen types have been widely applied to assess collagen distri-
bution in both normal and repair cartilage46. In the current study,
immunopositivity for type I collagen occurred throughout the
majority of the graft tissue, while type II collagen staining was
primarily concentrated to the lower regions of the cartilage nearest
the bone. Hence, a combination of types I and type II collagen was
seen in all samples evaluated in this study. This reﬂects the pres-
ence of ﬁbrocartilage, which, although not desirable, may go on to
mature to hyaline cartilage in some of the repair tissue,
Fig. 5. Correlation of IHC area and intensity scores for type II collagen with FT-IRIS-
derived parameters and histology or IHC scores; (A) IHC intensity score vs PG
content, p < 0.0001 (95% CI: 0.93e0.97), (B) IHC intensity score vs collagen integrity,
p < 0.0001 (95% CI: 0.96e0.98), (C) IHC area score vs OsScore, p ¼ 0.001 (95% CI:
0.43e0.93).
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II collagen is typically present in hyaline cartilage, it appears that
the tissue remodeling may be originating from the cartilage deep
zone, at the boneecartilage interface. Nonetheless, a greater
amount of collagen type II in this sample set was linked to a greater
improvement in Lysholm score. Unfortunately, since histological
analysis and immunostaining require actual tissue sections and
corresponding removal of some repair tissue, it is unrealistic to
expect these assays to be performed in a routine clinical procedure.FT-IR imaging spectroscopy has been used in cartilage tissue
assessment for over 15 years. The cartilage repair process has been
evaluated by FT-IRIS in two pre-clinical studies in rabbit models by
Kim et al.34, and by Terajima et al.47. In the Kim study, it was shown
that FT-IRIS analysis combined with magnetic resonance imaging
(MRI) T2 can be utilized to assess progression of the repair process
at the molecular level as an important step toward improved
monitoring of repair tissue maturation. In the Terajima study, FT-
IRIS evaluation of repair tissue was compared to biochemical
analysis of collagen cross-links and composition. Although the FT-
IRIS parameters paralleled the biochemical collagen data, there
was no correlation with a previously described FT-IRIS “crosslink”
parameter validated for type I collagen28 and biochemical crosslink
data, likely due to the combination of types I and II collagen in the
repair tissue. Clinically, cartilage repair tissue has not been evalu-
ated by FT-IRIS extensively, although studies of degenerated human
cartilage tissue have shown that FT-IR provides quantitative infor-
mation on compositional changes of collagen and PG. In general,
damaged tissue shows changes in collagen quantity and distribu-
tion, in collagen ﬁber orientation, and loss of PGs4,35,48.
The similar correlation found between FT-IRIS-derived molec-
ular parameters (of both relative PG/collagen content as well as the
collagen helical integrity) with improvement in Lysholm score,
compared to that seen with the IHC-determined type II collagen
content or OsScore for histology evaluation, indicates the potential
of FT-IRIS as a modality for assessing repair tissue. Moreover, our
work suggests that IHC and histology-derived scores provide very
little additional information to that derived from the FT-IRIS
parameters. It should be noted that recent studies have utilized
other FT-IRIS-determined parameters that can be more speciﬁc for
assessment of PG content in cartilage under certain conditions29,41.
The data presented here reﬂect an assessment of PG relative to
collagen, which is likely to be an important indicator of the quality
of the repair tissue.
In addition to the data on the distribution of themacromolecular
components of the repair tissue, FT-IRIS allows an assessment of
orientation of collagen ﬁbrils, which is an important indicator of
tissue integrity and function49. In contrast to normal cartilage, the
majority of collagen ﬁbrils in the repair tissue showed a random
alignment, with little zonal stratiﬁcation. Further, collagen ﬁbrils
with an alignment parallel to the surface were found in the deeper
regions, as opposed to on the surface, reﬂecting a suboptimal tissue
organization, as assessed by FT-IRIS, regardless of collagen type.
Collagen ﬁber orientation studies using polarized light microscope
and magnetic resonance imaging have suggested that the collagen
ﬁbers in normal cartilage curve from being perpendicular to the
surface in subchondral regions to being parallel to the surface at
superﬁcial regions50e52,which is similar to the orientations found in
the normal tissue analyzed in this study. Further, it has been shown
that the orientation of collagen ﬁbers is a key determinant of their
functionality in cartilage6. Therefore, improving the zonal stratiﬁ-
cation in repair tissue would likely enhance the tissue quality.
Interestingly, the collagen integrity parameter was greater in
regionswhere type II collagenwasmoreprevalent. Previousworkon
the origin of this molecular parameter found that a reduction in the
ratio of the 1338 cm1 absorbance to the amide II absorbance was
related to type II collagendegradation28.However, assessmentof the
differences in absorbance in this spectral region between types I and
II collagen has not yet been investigated. Based on the current
results, it is possible that changes in the spectral signature of the
1338 cm1 peak from the collagen molecule can be used as an
indicator of the presence of type II collagen in repair tissue.
Improvement in Lysholm score was signiﬁcantly and positively
correlated to the collagen helical integrity, to PG/collagen content,
IHC area score and OsScore. Together, these data suggest that
Fig. 6. Correlation of FT-IRIS-derived parameters with percentage LSI and IHC area score values; (A) Collagen integrity vs percentage LSI, p ¼ 0.001 (95% CI: 0.43e0.93), (B) PG
content vs percentage LSI, p ¼ 0.006 (95% CI: 0.25e0.89), (C) IHC area score vs percentage LSI, p ¼ 0.004 (95% CI: 0.27e0.89), (D) OsScore vs percentage LSI, p ¼ 0.006 (95% CI:
0.23e0.88).
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hyaline cartilage in the repair tissue. Hyaline cartilage gives the
desired biomechanical and viscoelastic properties to repair tissue
which ultimately determines its quality, and the clinical outcome of
cartilage repair process39. Henderson et al. have also found that
improving the clinical outcome of ACI treatment is related to the
amount of hyaline cartilage in repair tissue53.
Correlations of FT-IRIS-determined PG composition to cartilage
histology data based on Alcian blue and Safranin O staining have
been demonstrated previously4,28,41, but the current study is the
ﬁrst to show direct correlations between IHC-determined type IITable II
Regression analysis parameters for prediction of LSI with histology, IHC and FT-IRIS vari
Variables* R 95% CI of correlation R2
Histology 0.68 0.23e0.88 0.48
IHC 0.70 0.27e0.89 0.5
FT-IRIS 0.81 0.49e0.93 0.66
Histology þ FT-IRIS 0.82 0.51:0.94 0.67
IHC þ FT-IRIS 0.84 0.55e0.94 0.71
Histology þ IHC þ FT-IRIS 0.85 0.58e0.95 0.72
* Histology: OsScore; IHC: Immunohistochemistry area score; FT-IRIS parameters: PG
mination; RMSE ¼ Root mean square error of prediction.collagen and two different FT-IRIS parameters, relative PG/collagen
content and collagen helical integrity. Thus, the present data
demonstrate the feasibility of assessment of the quality of the
repair tissue post-ACI using a spectroscopic method without the
need for biochemical assays and histology or IHC. Clearly, the ability
of infrared spectroscopy to probe several macromolecules simul-
taneously makes this a very powerful tool for assessment of repair
tissue.
In spite of the advantages of FT-IRIS in evaluating post-ACI
repair tissue, there are also limitations to the use of this tech-
nique. Although we were able to assess tissue properties, there areables
RMSE p value (regression) p value (F-test)
6.60 0.006 e
7.07 0.004 e
4.52 0.002 e
4.88 0.003 Compared to:
Histology: 0.12
FT-IRIS: 0.11
4.72 0.004 Compared to:
IHC: 0.15
FT-IRIS: 0.11
3.63 0.013 Compared to: Histology: 0.18
IHC: 0.094
FT-IRIS: 0.081
IHC þ FT-IRIS: 0.07
/Am I and collagen integrity; R ¼ Correlation coefﬁcient; R2 ¼ Coefﬁcient of deter-
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how well the repair tissue integrates laterally to surrounding
normal tissue, andmechanical competence of the tissue. Here, with
FTIR imaging spectroscopy, we were able to determine the tissue
composition at relatively high pixel resolution (25 mm sampling).
However, when transferring this methodology to an infrared ﬁber
optic probe, the region sampled will be in the order of w1 mm
diameter36, and thus only a few spectra per area of interest will be
obtained. Further, the mid-infrared ﬁber optic probes that are
commercially available acquire data in reﬂectance or attenuated
total reﬂectance mode, which enables sampling of the tissue
surface only. Nonetheless, infrared ﬁber optic probe spectra
collected from the cartilage surface in degenerative cartilage have
been shown to correlate to full-depth tissue composition, and as
well as having the advantage of being non-destructive, also have
the advantage of data acquisition in approximately 1 minute36.
Using a near infrared probe, it would be possible to do full-depth
sampling, but data interpretation is not as well understood as that
in mid-infrared region54. Further development of the ﬁber optic
technique for repair cartilage assessment would require additional
validation, but such advances could result in an important prog-
nostic tool to accurately predict the likelihood of treatment efﬁcacy
in a non-destructive manner.
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